Moreover, this model exhibited significant elevations in pro-inflammatory cytokines (e.g., MCP-1, IL-1β, IL-6, IL-17A) and MMP activity (MMP2 and MMP9), validating its relevance for investigating AAA progression and potential therapeutic interventions. This evidence concerns the gene MMP9 and triple-A syndrome.